Semerenko v. Cendant Corp.

223 F.3d 165, 2000 WL 1131928
CourtCourt of Appeals for the Third Circuit
DecidedJune 16, 2000
Docket99-5355, 99-5356
StatusUnknown
Cited by21 cases

This text of 223 F.3d 165 (Semerenko v. Cendant Corp.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Third Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Semerenko v. Cendant Corp., 223 F.3d 165, 2000 WL 1131928 (3d Cir. 2000).

Opinion

OPINION OF THE COURT

ALARCON, Senior Circuit Judge.

I

The P. Schoenfeld Asset Management LLC and the class of similarly situated investors (collectively, the “Class”) appeal from the order of the district court dismissing their claims for securities fraud pursuant to Rule 12(b)(6) of the Federal Rules of Civil Procedure. The Class’s complaint was filed under § 10(b) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5. The complaint also alleged that the individual defendants were liable for the underlying violations of § 10(b) and Rule 10b-5 as control persons under § 20(a) of the Exchange Act.

We conclude that the complaint alleges sufficient facts to establish the elements of reliance and loss causation, and that the district court applied the incorrect analysis for determining whether the complaint alleges that the purported misrepresentations were made “in connection with” the purchase or the sale of a security. Because the standard that we have articulated for the “in connection with” requirement is different from the one applied by the district court, we vacate the judgment below and remand the matter for further proceedings. Given that we do not resolve whether the dismissal was proper under § 10(b) and Rule 10b-5, we do not address the dismissal of the Class’s claim under § 20(a).

II

The Class filed this action against the Cendant Corporation (“Cendant”), 1 its former officers and directors Walter A. Forbes, E. Kirk Shelton, Christopher K. McLeod, and Cosmo Corigliano (the “individual defendants”), and its accountant Ernst & Young LLP (“Ernst & Young”) (collectively, the “defendants”). The Class alleges that the defendants violated § 10(b) and Rule 10b-5 by making certain misrepresentations about Cendant during a tender offer for shares of American Bankers Insurance Group, Inc. (“ABI”) common stock. The Class consists of persons who purchased shares of ABI common stock during the course of the tender offer. The class period runs from January 27, 1998 to October 13, 1998. The complaint does not allege that any member of the Class purchased securities issued by Cendant, or that any member of the Class tendered shares of ABI common stock to Cendant. Instead, it alleges that the defendants made certain misrepresentations about Cendant that artificially inflated the price at which the Class purchased their shares of ABI common stock, and that the Class suffered a corresponding loss when those misrepresentations were disclosed to the public and the merger agreement was terminated. In light of the procedural *170 posture of this case, we must assume the truth of the facts alleged in the complaint. See In re Burlington Coat Factory Sec. Litig., 114 F.3d 1410, 1420 .(3d Cir.1997).

On December 22, 1997, the American International Group, Inc. (“AIG”) announced that it would acquire one hundred percent of the outstanding shares of ABI common stock for $47 per share. On January 27, 1998, Cendant made a competing tender offer to purchase the same shares at a price of $58 per share, or a total price of approximately $2.7 billion. In conjunction with its tender offer, Cendant filed with the Securities and Exchange Commission (the “SEC”) a Schedule 14D-1 that overstated its income during prior financial reporting periods.

On March 3, 1998, AIG matched Cen-dant’s bid and offered to pay ABI shareholders $58 for each share of outstanding ABI common stock. Cendant eventually raised its bid price to $67 per share. It then executed an agreement to purchase ABI for approximately $3.1 billion, payable in part cash and in part shares of Cendant common stock. Cendant filed an amendment to its Schedule 14D-1 on March 23, 1998 reporting the terms of the merger agreement. Eight days later, Cendant filed a Form 10-K reporting its financial results for the 1997 fiscal year.

After the close of trading on April 15, 1998, Cendant announced that it had discovered potential accounting irregularities, and that its Audit Committee had engaged Willkie, Farr & Gallagher and Arthur Andersen LLP to perform an independent investigation. Cendant also announced that it had retained Deloitte & Touche LLP to reaudit its financial statements, and that “[i]n accordance with [Statement of Accounting Standards] No. 1, the Company’s previously issued financial statements and auditors’ reports should not be relied upon .” Nevertheless, the April 15, 1998 announcement reported that the irregularities occurred in a single business unit that “accounted for' less than one third” of Cendant’s net income, and it indicated that Cendant would restate its annual and quarterly earnings for the 1997 fiscal year by $0.11 to $0.13 per share. Immediately after Cendant disclosed the accounting irregularities, the price of ABI common stock dropped from $64-7/8 to $57-3/4, representing an eleven percent decrease from the price at which the shares had been trading.

Following the April 15 announcement, Cendant made several public statements in which it represented that it was committed to completing the merger with ABI notwithstanding the discovery of the accounting irregularities. On April 27, 1998, Walter A. Forbes, the chairman of the board of directors of Cendant, and Henry R. Silverman, the president and the chief executive officer of Cendant, issued a letter to Cendant shareholders, which was published in the financial press. That letter states:

We are outraged that the apparent misdeeds of a small number of individuals within a limited part of our company has adversely affected the value of your investment — and ours — in Cendant. We are working together diligently to clear this matter up as soon as possible. We fully support the Audit Committee’s investigation and continue to believe that the strategic rationale and industrial logic of the HFS/CUC merger that created Cendant is as compelling as ever.
Cendant is strong, highly liquid, and extremely profitable. The vast majority of Cendant’s operating businesses and earnings are unaffected and the prospects for the Company’s future growth and success are excellent.
We have reaffirmed our commitment to completing all pending acquisitions: American Bankers, National Parking Corporation and Providian Insurance.

In a press release issued on May 5, 1998, Cendant stated that “over eighty percent of the Company’s net income for the first quarter of 1998 came from Cendant busi *171 ness units not impacted by the potential accounting irregularities.”

On July 14, 1998, Cendant revealed that the April 15, 1998 announcement anticipating the restatement of its financial results for the 1997 fiscal year was inaccurate, and that the actual reduction in income Would be twice as much as previously announced. Cendant further acknowledged that its investigation had uncovered several accounting irregularities that had not previously been disclosed, and that those accounting irregularities affected additional Cendant business units and other fiscal years. Cendant estimated that earnings would be reduced by as much as $0.28 per share in 1997.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
223 F.3d 165, 2000 WL 1131928, Counsel Stack Legal Research, https://law.counselstack.com/opinion/semerenko-v-cendant-corp-ca3-2000.